Patents Assigned to Reckitt Benckiser Healthcare (UK) Limited
-
Publication number: 20100147864Abstract: A packaging for a pharmaceutical product comprising a body portion (10) having an opening (24) for dispensing the pharmaceutical product; and a lid portion (12) adapted to seal the opening by means of a projection (20) adapted to be received in the opening of the body, wherein the projection is adapted to form a substantially airtight bore seal with the opening.Type: ApplicationFiled: July 21, 2005Publication date: June 17, 2010Applicant: RECKITT BENCKISER HEALTHCARE (UK) LIMITEDInventors: Andrew Howes, Steed Hubbard, John Lawrence, Andrew Newhall, Mark Pearson
-
Publication number: 20100120812Abstract: An analgesic composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naltrexone such that the ratio by weight of buprenorphine to naltrexone delivered to or reaching the plasma of a patient is in the range 100:1 to 5000:1. The analgesic action of the buprenorphine is potentiated by the low dose of naltrexone. Also provided are a method of treatment of pain and the use of buprenorphine and naltrexone for the manufacture of a medicament.Type: ApplicationFiled: February 15, 2008Publication date: May 13, 2010Applicant: Reckitt Benckiser Healthcare (UK) LimitedInventors: Christopher Bourne Chapleo, Neil Hyde
-
Publication number: 20090166244Abstract: A tablet housing comprises two generally rigid leaves hinged together, each leaf having (1) recesses or apertures to align with and receive the projecting tablet cells of a blister pack of tablets, and (2) closure means. The housing may be opened in order to access tablets and closed in order to protect and retain tablets.Type: ApplicationFiled: October 9, 2006Publication date: July 2, 2009Applicant: RECKITT BENCKISER HEALTHCARE (UK) LIMITEDInventor: Richard Seymour
-
Publication number: 20090152156Abstract: A pack for medicinal tablets has two parts hinged together, each part having pockets containing tablets. The pockets may be displaced to expel the tablets through a foil sheet.Type: ApplicationFiled: February 25, 2009Publication date: June 18, 2009Applicant: RECKITT BENCKISER HEALTHCARE (UK) LIMITEDInventors: Christopher Michael PENFOLD, Stephen John BRITTON-WILLIAMS, Stuart Richard MAY
-
Publication number: 20090142392Abstract: A process for producing a granular composition comprising a plurality of solidified melt granules including a non-steroidal anti-inflammatory drug (NSAID) and paracetamol (acetaminophen), the process comprising the steps of: (a) forming a melt mixture by mixing a molten NSAID free acid and paracetamol, optionally with one or more excipients; and (b) forming the melt mixture into solidified melt granules. The granules are useable in compositions for treating pain and/or inflammation and/or fever.Type: ApplicationFiled: September 7, 2006Publication date: June 4, 2009Applicant: RECKITT BENCKISER HEALTHCARE (UK) LIMITEDInventor: Robert Sherry
-
Patent number: 7402591Abstract: An analgesic composition in parenteral unit dosage form or in a unit dosage form suitable for delivery via the mucosa comprising an amount of buprenorphine which is less than the clinical dose required to achieve pain relief and an amount of naloxone such that the ratio by weight of buprenorphine to naloxone is in the range of from 12.5:1 to 27.5:1, or an amount of naltrexone or nalmefene such that the ratio by weight of buprenorphine to naltrexone or nalmefene is in the range of from 12.5:1 to 22.5:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, naltrexone or nalmefene.Type: GrantFiled: October 20, 2005Date of Patent: July 22, 2008Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventors: Christopher Bourne Chapleo, Nicolas Calvert Varey, Keith McCormack
-
Publication number: 20080085308Abstract: A pharmaceutical composition comprising a granular component comprising a plurality of solidified melt granules of a sugar alcohol having a salt of a non-steroidal anti-inflammatory drug (NSAID salt) and paracetamol contained therein.Type: ApplicationFiled: August 8, 2005Publication date: April 10, 2008Applicant: RECKITT BENCKISER HEALTHCARE (UK) LIMITEDInventor: Robert Sherry
-
Publication number: 20070254028Abstract: A pharmaceutical composition comprising a granular component comprising a plurality of solidified melt granules of a sugar alcohol having a salt of non-steroidal anti-inflammatory drug (NSAID salt) contained therein.Type: ApplicationFiled: August 8, 2005Publication date: November 1, 2007Applicant: Reckitt Benckiser Healthcare (UK) LimitedInventor: Robert Sherry
-
Patent number: 7288225Abstract: Ispaghula (material from the plant Plantago ovata, useful as an agent in relieving constipation, is subjected to treatment with -radiation at a dose of up to 13 kGy, and preferably in the range 5-10 kGy. As well as effecting sterilisation of the ispaghula, this dose of irradiation has been shown to offer surprising rheological advantages.Type: GrantFiled: May 10, 2001Date of Patent: October 30, 2007Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventors: Michael Edward Havler, Peter William Dettmar, Glyn Owen Phillips, Saphwan Al-Assaf
-
Patent number: 7171996Abstract: A measuring and dispensing device (2) for attachment to the cap (14) of a bottle (16) of liquid medicine comprises on one of its sides a socket formation (6), by means of which it may be releasably attached to the cap, and on another side a concave formation (4) for receiving liquid medicine.Type: GrantFiled: December 5, 2003Date of Patent: February 6, 2007Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventor: Timothy Perry
-
Patent number: 6995169Abstract: An analgesic composition in parenteral unit dosage form or in a unit dosage form suitable for delivery via the mucosa comprising an amount of buprenorphine which is less than the clinical dose required to achieve pain relief and an amount of naloxone such that the ratio by weight of buprenorphine to naloxone is in the range of from 12.5:1 to 27.5:1, or an amount of naltrexone or nalmefene such that the ratio by weight of buprenorphine to naltrexone or nalmefene is in the range of from 12.5:1 to 22.5:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, naltrexone or nalmefene.Type: GrantFiled: May 14, 2002Date of Patent: February 7, 2006Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventors: Christopher Bourne Chapleo, Nicolas Calvert Varey, Keith McCormack
-
Publication number: 20050244519Abstract: The present invention provides an ingestible composition comprising a fibre or sacharide bulking agent, an ingestible silica, and at ingestible surfactant. The provision of the silica and the surfactant provides a synergistic benefit in the dispersal of the bulking agent in water thus making if easier and/or quicker to obtain an imbibable liquid. The bulking agent may be ispaghula, a natural material of benefit in promoting good bowel function.Type: ApplicationFiled: July 11, 2003Publication date: November 3, 2005Applicant: Reckitt Benckiser Healthcare (UK) LimitedInventors: Peter Dettmar, Kevin McKie, Michael Havler
-
Patent number: 6610667Abstract: Pharmaceutical compositions having improved bioadhesive properties are produced by combining an alginate, xanthan gum and/or a carageenan gum and a glucomannan and/or a galactomannan. The composition can provide both a protecting and a healing effect on mucosal surface.Type: GrantFiled: January 7, 2002Date of Patent: August 26, 2003Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventors: Peter William Dettmar, Paul Andrew Dickson, Frank Chadwick Hampson, Ian Gordon Jolliffe
-
Publication number: 20030130229Abstract: A pharmaceutical composition is provided for use in the healing of cells containing about 0.0001 percent weight per volume (% w/v) to about 2% w/v of an alginic acid or a salt of alginic acid having a molecular weight in the range of greater than about 250,000 to about 1,000,000, provided that if the composition additionally contains an alginic acid or a salt of alginic acid having a molecular weight in the range of about 20,000 to about 250,000, it is present in an amount of less than 1% w/w. The use of the pharmaceutical composition for the healing cells in a mammal, preferably mucosal cells is also provided.Type: ApplicationFiled: September 10, 2002Publication date: July 10, 2003Applicant: Reckitt Benckiser Healthcare (UK) LimitedInventors: Raffaele Del Buono, Peter William Dettmar, Frank Chadwick Hampson, Ian Gordon Jolliffe, Paul Murray McPherson, Edvar Onsoyen, Massimo Pignatelli, Peter Edward Ross
-
Patent number: 6589551Abstract: An oral unit dosage comprising a substrate defining a plurality of discrete reservoirs each containing a liquid fill for release in the mouth.Type: GrantFiled: February 15, 2001Date of Patent: July 8, 2003Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventor: Ian Gordon Jolliffe
-
Patent number: 6391294Abstract: A pharmaceutically acceptable bio-adhesive coating, film or gel is formed in situ at a body surface by the reaction of (i) an anionic polymer or tripolyphosphate and (ii) a cationic polymer in the presence of water. The two components are supplied either as separate aqueous solutions or in a single non-aqueous formulation, which can be a liquid suspension tablet, capsule or powder.Type: GrantFiled: April 12, 2000Date of Patent: May 21, 2002Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventors: Peter William Dettmar, Ian Gordon Jolliffe, Oyvind Skaugrud
-
Patent number: 6306789Abstract: Mucoadhesive granules comprising a) carbomer and/or a salt thereof; and b) an inert filler. The granules preferably further comprise a pharmaceutically active agent suitable for sustained release into the gastrointestinal tract or for targeted delivery to the gastrointestinal mucosa.Type: GrantFiled: October 12, 1999Date of Patent: October 23, 2001Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventors: Peter William Dettmar, Paul Andrew Dickson, Frank Chadwick Hampson, Ian Gordon Jollife, William Peers
-
Patent number: D524167Type: GrantFiled: July 25, 2005Date of Patent: July 4, 2006Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventor: Susan Wilson
-
Patent number: D486741Type: GrantFiled: August 14, 2002Date of Patent: February 17, 2004Assignee: Reckitt Benckiser Healthcare (UK) LimitedInventor: Kenneth Arthur Houghton